ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 7 analysts with an average price target of $199.68. This is a potential upside of $188.67 (1713.62%) from yesterday's end of day stock price of $11.01.

Atara Biotherapeutics's activity chart (see below) currently has 60 price targets and 66 ratings on display. The stock rating distribution of ATRA is 23.53% HOLD, 35.29% SELL and 41.18% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.74% with an average time for these price targets to be met of 57.2 days.

Highest price target for ATRA is $35, Lowest price target is $35, average price target is $199.68.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 22-May-2024. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 4 are a HOLD (23.53%), 6 are a SELL (35.29%), 7 are a BUY (41.18%).

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


1 months 29 days ago

1/4 (25%)

$376.5 (88.90%)



8 months 12 days ago

1/2 (50%)

$814 (86.97%)



8 months 12 days ago

0/3 (0%)

$436 (74.02%)



$23.99 (217.89%)


11 months ago

13/13 (100%)

$-0.25 (-0.71%)



1 years 11 months 13 days ago

3/3 (100%)

$0.54 (4.01%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 57.2 days on average for the stock forecasts to be realized with a an average price target met ratio 37.74

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?


Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

Yigal Nochomovitz works at CITI and has 22 price targets and 15 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $613.99

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

John Newman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?